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Abstract
The prognosis for patients with lymphoma of mucosa-associated lymphoid 
tissue (MALT) lymphoma is good, but multifocal lesions appear in 30–40% 
of patients. We report a 65-year-old woman who presented with painless, 
firm nodules on her right arm and face. Nine years previously, the patient 
presented at Tzu Chi Hospital with hoarseness and a sensation of a lump 
in the throat. She was first diagnosed with primary MALT lymphoma of 
the larynx. Subsequently, multiple painless nodules were noted on her 
right eyelid, right axilla, and right arm. The intervals between recurrences 
became shorter and skin lesions relapsed more frequently. The nodules 
were resected and histopathology showed small B-cells including marginal 
zone (centrocyte-like) cells, monocytoid cells, and small lymphocytes. Most 
centrocyte-like cells showed positive staining for CD20 marker in the 
plasma membrane—this is entirely specific for B-lymphocytes. Follicular 
dendritic-like cells had positive staining with stromal cell-derived factor-1α 
(SDF1α) antibody. The nuclei of the centrocyte-like cells stained positive 
with CXCR4, a ligand of SDF1α. This may indicate that MALT lymphoma 
grows in a self-sustained microenvironment. [Tzu Chi Med J 2009;21(3):
261–264]
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1. Introduction
Marginal zone B cell lymphoma (MZL) can be divided 
to three subgroups: the extranodal mucosa-associated 
lymphoid tissue (MALT) type, splenic MZL, and nodal 
MZL. MZL occurs in 5–17% of all non-Hodgkin lym-
phomas, and 50–70% of MZL is MALT lymphoma. In 
1983, Isaacson and Wright first coined the term 
MALT lymphoma [1]. In 1991, researchers found 
that MALT lymphoma was strongly associated with 
Helicobacter pylori infection [2]. Subsequently, 
other infections were found to cause MALT lymphoma, 
including Borrelia burgdorferi (Lyme disease) in 
cutaneous MALT lymphoma [3], Chlamydia psittaci 
in ocular adnexal MALT lymphoma [4], and 
Campylobacter jejuni in immunoproliferative small 
intestinal disease [5]. Genetic alterations were also 
noted, including t(11;18)(q21;q21) in gastric, skin, 
salivary, lung, and thyroid MALT lymphoma; t(14;18)
(q32;q21) in gastric, skin, salivary, lung, and liver 
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MALT lymphoma; and t(1;14)(p22;q32) in salivary and 
lung MALT lymphoma [6].
We report a patient with a relapse of laryngeal MALT 
lymphoma in the skin with pathology demonstrating 
small B-cells including marginal zone (centrocyte-
like) cells, monocytoid cells, and small lymphocytes. 
Expression of stromal cell-derived factor-1α (SDF1α) 
and CXCR4 was positive in follicular dendritic-like cells 
and centrocyte-like cells, respectively.
2. Case report
A 65-year-old woman presented with painless, firm 
nodules on her right arm and face. Nine years previ-
ously, she had presented with hoarseness and a sen-
sation of a lump in the throat at Tzu Chi Hospital and 
had been diagnosed with primary lymphoma of MALT 
of the larynx (1.5 cm in size) [7]. Radiation therapy 
was done at Koo Foundation Sun Yat-Sen Cancer 
Center—after this, her symptoms disappeared. Six 
and 7 years later, painless nodules were reported on 
the right eyelid and right axilla, respectively. Two years 
later, another nodule was also reported in the right 
axilla. All nodules were resected and pathologic re-
ports were positive for MALT lymphoma. Over the next 
3 months, multiple nodules developed over the right 
upper extremity and forehead. The largest nodule 
appeared on the right arm and it enlarged insidiously 
to 1.2 cm in diameter. Other nodules that were deep 
red to violaceous infiltrated plaques or grouped nod-
ules appeared with random distribution and in quick 
succession (Fig. 1). An area of infiltrated erythema 
on the surface surrounded some nodules.
A skin biopsy was performed on the right arm. 
Histopathology showed a well-defined tumor with 
dense small lymphocytic infiltration. No angioinvasion 
or epithelium invasion was found. High power views 
showed morphologically heterogeneous small B-cells 
including marginal zone (centrocyte-like) cells, mono-
cytoid cells, and small lymphocytes (Figs. 2A and 2B). 
Immunoreactivity was performed including CD20 
antibody (dilution titer 1:100; Dako Denmark A/S, 
Glostrup, Denmark), CD45RO antibody (dilution titer 
1:100; Dako Denmark A/S), SDF1α antibody (dilution 
titer 1:50; R&D Systems, Minneapolis, MN, USA) and 
CXCR4 antibody (dilution titer 1:100; R&D Systems) 
(Figs. 2C–F). There were very few positively stained 
CD45RO T-lymphocytes in the tumor mass. There 
was positive staining for CD20 markers in the plasma 
membrane in B-lymphocytes, demonstrating mark-
ers entirely specific for MALT lymphoma. Follicular 
dendritic-like cells had positive staining with SDF1α 
antibody. The nuclei of the centrocyte-like cells stained 
positive with CXCR4, a ligand of SDF1α.
Normal liver function and renal function were noted 
in a serum examination. Serum lactate dehydrogenase 
was also within the normal range. Generalized lym-
phadenopathy was not found. A whole body com-
puted tomography scan also did not show laryngeal 
relapse. The patient did not have fever, weight loss, 
or fatigue (B symptoms). The final diagnosis in this 
patient was a relapse of laryngeal MZL of MALT lym-
phoma in the skin. Systemic chemotherapy with 
chlorambucil 4 mg/day was given for 1 month. Six 
months later, a skin lesion relapsed on the face, and 
therapy with chlorambucil 4 mg/day was given for 3 
weeks. No skin or systemic recurrence was found after 
2 years of follow-up.
3. Discussion
MALT lymphoma comprises morphologically hetero-
geneous small B-cells including marginal zone 
(centrocyte-like) cells, monocytoid cells, small 
Fig. 1 — (A) Multiple violaceous, painless, firm nodules on the right arm. (B) Multiple skin-colored nodules on the 
forehead.
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lymphocytes, immunoblasts, and centroblast-like 
cells. The median age of onset for MALT lymphoma is 
60 years [8]. The primary sites of MALT lymphoma 
include the gastrointestinal tract (50%) and locations 
outside the gastrointestinal tract, including the lung 
(14%), salivary gland (14%), orbit (12%), skin (11%), 
thyroid (4%), and breast (4%) [4]. Multifocal lesions 
appear in 30–40% of patients [9]. CXCR4 and CXCR5 
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Fig. 2 — (A) A well-defined tumor with dense lymphocytes infiltrating the dermis [hematoxylin & eosin (H&E); original 
magnification, 125´]. (B) Centrocyte-like cells (arrows) and small lymphocytes (arrowheads) infiltrating the dermis 
(H&E; original magnification, 400´). (C) Expression of CD45RO-positive T cells (arrows) (H&E; original magnification, 
400´). (D) Most centrocyte-like cells express CD20-positive staining of the plasma membrane of B cells (H&E; original 
magnification, 400´). (E) Expression of SDF1a-positive follicular dendritic-like cells (arrows) in the dermis (H&E; origi-
nal magnification, 400´). (F) CXCR4-positive staining of the nucleus of the centrocyte-like cells (H&E; original magni-
fication, 400´).
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have been demonstrated as the main chemokine re-
ceptors involved in B cell homing to other tissues 
[10–12]. SDF1/CXCR4 interaction can induce cell 
migration and inflammation processes and this sig-
nal activates ERK1/2 and stimulates cell proliferation 
and survival in several human cancer types [13]. 
In addition, almost all of the tumors described so far 
were found to express CXCR4 and were responsive 
to an SDF-1 gradient [14]. This may explain why some 
lymphomas that express chemokine receptors have 
a wide dissemination to the lymph nodes, bone mar-
row, and peripheral blood; others are confined to a 
limited number of organs with minimal or no lymph 
node involvement.
In the patient outlined in this study, immunostain-
ing of CXCR4 showed positive centrocyte-like cells. 
The expression of CXCR4 in MALT lymphoma may 
significantly indicate a wide organ dissemination pat-
tern. Scattered follicular centrocyte-like cells and 
small stromal cells had positive staining with SDF1α 
antibody. This suggests that elevated tissue levels of 
SDF1α are associated with increased attraction of 
circulating cancer cells in different parts of the body 
and may indicate a self-sustained microenvironment 
in MALT lymphoma. Our patient developed MALT 
lymphoma in the larynx first, and the lesion disap-
peared after radiotherapy. The symptoms of hoarse-
ness and a sensation of a lump in the throat have not 
recurred. However, the skin lesions relapsed more 
frequently and the intervals between recurrences 
became shorter. This may indicate circulatory seeding 
of cancer cells by SDF1/CXCR4 interaction in tumor 
cell growth.
Local radiation or excision is the choice for MALT, 
but wide organ dissemination may develop even in 
the absence of evident clinical symptoms. Because 
histological examination of the skin biopsy showed 
positive staining for SDF1 and CXCR4, we propose 
that systemic chemotherapy may be needed to treat 
the multifocal lesions of MALT lymphoma as early as 
possible. This may also suggest new avenues of treat-
ment through elimination of CXCR4-positive cancer 
cells.
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